Mitra A B, Murty V V, Singh V, Li R G, Pratap M, Sodhani P, Luthra U K, Chaganti R S
Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
J Natl Cancer Inst. 1995 May 17;87(10):742-5. doi: 10.1093/jnci/87.10.742.
Development of uterine cervical cancer is preceded by preneoplastic proliferative changes in the cervical epithelium called "intra-epithelial neoplasia" or "dysplasia." The genetic basis of the origin and progression of such preneoplastic lesions is not known. By analysis of carcinomas for loss of constitutional heterozygosity (LOH), we have previously shown a high frequency of allelic loss in the short arm of chromosome 5 (5p), suggesting loss of a candidate tumor suppressor gene located in 5p and associated with the development of this tumor.
To further understand the role of genetic alterations that affect 5p in cervical carcinogenesis, we evaluated the status of microsatellite polymorphisms at five loci mapped to 5p14-ter in precancerous and cancerous lesions.
Biopsy specimens from two groups of patients were analyzed for genetic alterations affecting 5p. One group comprised 14 cases of precancerous lesions (i.e., dysplasias) and five cases of carcinoma in situ (CIS); the second group comprised 46 previously untreated patients with invasive carcinoma. Tumor and normal DNAs were analyzed by polymerase chain reaction for genetic losses and instability at five polymorphic microsatellite loci (D5S392, D5S406, D5S208, D5S117, and D5S432) mapped to 5p.
LOH was observed in 25 (55.6%) of 45 informative invasive carcinomas, one (20%) of five cases of CIS, and three (21%) of 14 precancerous lesions. Among the loci tested, D5S406 (5p15.1-15.2) exhibited LOH in 12 (48%) of 25 invasive carcinomas, one (33%) of three cases of CIS, and three (60%) of five precancerous lesions, suggesting this to be the site in 5p of the novel candidate tumor suppressor gene. In addition, replication error-type alterations were noted in the 5p14-ter region in six (13%) of 46 invasive carcinomas, two (40%) of five cases of CIS, and three (21%) of 14 precancerous lesions. Instability affected D5S406 in eight (66.7%) of 12 instances that showed microsatellite instability.
These observations suggest that allelic loss and microsatellite instability in the region of D5S406 may play a role early in the development of cervical carcinoma and identify the site of a candidate tumor suppressor gene. These genetic markers (allelic loss and microsatellite instability) may also define CIS and precancerous lesions at high risk for progression to invasive cancer.
The future molecular cloning of the candidate tumor suppressor gene at 5p15.1-15.2 may provide new insights into the genetic mechanisms of cervical carcinogenesis. Analysis and clinical follow-up of a large cohort of prospectively ascertained cases of precancerous lesions would help to validate the usefulness of these markers.
子宫颈癌的发生之前,宫颈上皮会出现癌前增殖性变化,称为“上皮内瘤变”或“发育异常”。此类癌前病变发生和进展的遗传基础尚不清楚。通过分析癌组织中体质性杂合性缺失(LOH)情况,我们之前已表明,5号染色体短臂(5p)存在高频等位基因缺失,提示位于5p的一个候选肿瘤抑制基因缺失,且与该肿瘤的发生有关。
为进一步了解影响5p的基因改变在子宫颈癌发生中的作用,我们评估了癌前病变和癌性病变中位于5p14 - ter的5个位点的微卫星多态性状态。
对两组患者的活检标本进行分析,以确定影响5p的基因改变。第一组包括14例癌前病变(即发育异常)和5例原位癌(CIS);第二组包括46例未经治疗的浸润癌患者。通过聚合酶链反应分析肿瘤和正常DNA,以检测位于5p的5个多态性微卫星位点(D5S392、D5S406、D5S208、D5S117和D5S432)的基因缺失和不稳定性。
在45例信息充分的浸润癌中,有25例(55.6%)出现LOH;5例CIS中有1例(20%)出现LOH;14例癌前病变中有3例(21%)出现LOH。在所检测的位点中,D5S406(5p15.1 - 15.2)在25例浸润癌中有12例(48%)出现LOH,在3例CIS中有1例(33%)出现LOH,在5例癌前病变中有3例(60%)出现LOH,提示该位点可能是5p上新候选肿瘤抑制基因的位点。此外,在46例浸润癌中有6例(13%)、5例CIS中有2例(40%)、14例癌前病变中有3例(21%)在5p14 - ter区域出现复制错误型改变。在12例显示微卫星不稳定性的病例中,有8例(66.7%)的不稳定性影响D5S406。
这些观察结果表明,D5S406区域的等位基因缺失和微卫星不稳定性可能在子宫颈癌发生早期起作用,并确定了一个候选肿瘤抑制基因的位点。这些遗传标记(等位基因缺失和微卫星不稳定性)也可能用于定义进展为浸润癌风险较高的CIS和癌前病变。
未来对5p15.1 - 15.2处候选肿瘤抑制基因的分子克隆可能会为子宫颈癌发生的遗传机制提供新见解。对大量前瞻性确定的癌前病变病例进行分析和临床随访将有助于验证这些标记的实用性。